PedAM
Pediatric Disease Annotations & Medicines
| Disease | c syndrome |
| Phenotype | C0020676|hypothyroidism |
| Sentences | 15 |
| PubMedID- 26443114 | This paper presents two patients, a 45-year-old male and a 72-year-old male, with primary hypothyroidism who due to nephrotic syndrome required large amounts of levothyroxine. |
| PubMedID- 22167590 | hypothyroidism in children with steroid-resistant nephrotic syndrome. |
| PubMedID- 21512964 | Subclinical hypothyroidism and the prevalence of the metabolic syndrome. |
| PubMedID- 25053728 | Background: the association of subclinical hypothyroidism (sch) with insulin resistance, metabolic syndrome (ms), and coronary atherosclerosis is uncertain. |
| PubMedID- 23584882 | Subclinical non-autoimmune hypothyroidism in children with steroid resistant nephrotic syndrome. |
| PubMedID- 26388669 | (54) there was no significant difference between the rate of hypothyroidism in patients with metabolic syndrome and those without. |
| PubMedID- 24619737 | Conclusions: subclinical hypothyroidism was associated with metabolic syndrome components in male workers and not in females. |
| PubMedID- 23565417 | hypothyroidism in metabolic syndrome. |
| PubMedID- 25572759 | Presence and association of sub clinical hypothyroidism in subjects with metabolic syndrome. |
| PubMedID- 26323464 | The effect of hypothyroidism occurring in patients with metabolic syndrome. |
| PubMedID- 20651468 | Conclusions: metabolic syndrome is increased in patients with hypothyroidism, therefore hypothyroidism should be considered in newly diagnosed metabolic syndrome patients. |
| PubMedID- 25574328 | While some reports suggest that metabolic syndrome is associated with subclinical hypothyroidism, this concept is largely under investigated in nigerian adults with metabolic syndrome. |
| PubMedID- 26508200 | Iodine-induced non-autoimmune hypothyroidism in a patient with steroid-resistant nephrotic syndrome. |
| PubMedID- 22183820 | The recognized link between hypothyroidism and elements of the metabolic syndrome may explain this association. |
| PubMedID- 22194758 | We excluded premenopausal women, individuals younger than 20 years or older than 70 years, those with hypercholesterolemia (type i, iii, iv, v), homozygous familial hypercholesterolemia, those using cholesterol lowering agents (hmg-coa reductase inhibitors, bile acid sequestrants and nicotinic acid within 6 weeks, fibrate within 8 weeks, probucol within 1 year), the use of cyclosporine or antifungal agents (azole), severe left ventricular dysfunction (an ejection fraction <35%), active liver disease or hepatic dysfunction {alanine aminotransferase (alt) and aspartate aminotransferase (ast) >20% of the normal value}, renal dysfunction (serum serum creatinine >1.8 mg/dl), hypothyroidism, secondary hypercholesterolemia due to nephrotic syndrome, partial ileal bypass, hypersensitivity to a hmg-coa reductase inhibitor or an ace inhibitor and participation in another clinical trial. |
Page: 1